SUMMIT THERAPEUTICS INC shareholders Q2 2024

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 127 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

SUMMIT THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Baker Brothers Advisors 23,222,222$181,133,3322.32%
Anson Funds Management LP 941,908$7,346,8820.88%
QVT Financial LP 575,705$4,490,4990.42%
Wealth Management Partners, LLC 42,000$327,6000.16%
Pinpoint Asset Management Ltd 120,746$941,8190.13%
VANCE WEALTH, INC. 39,266$306,2750.13%
Sargent Investment Group, LLC 72,000$561,6000.12%
China Universal Asset Management Co., Ltd. 82,473$643,2890.09%
Caption Management, LLC 723,700$5,644,8600.09%
SECTORAL ASSET MANAGEMENT INC 25,000$195,0000.08%
Caption Management, LLC 499,100$3,892,9800.06%
FULLCIRCLE WEALTH LLC 12,209$121,8460.06%
HoyleCohen, LLC 86,408$673,9830.05%
Virtus ETF Advisers LLC 11,190$87,2820.04%
Alpine Global Management, LLC 29,149$227,3620.04%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$305,5730.03%
WORLD EQUITY GROUP, INC. 12,779$99,6760.03%
Blankinship & Foster, LLC 12,777$99,6610.03%
BENDER ROBERT & ASSOCIATES 14,059$109,6600.02%
FPC INVESTMENT ADVISORY, INC. 1,946$18,1180.02%
External links

This page lists SUMMIT THERAPEUTICS INC's shareholders in Q2 2024. To view SUMMIT THERAPEUTICS INC's shareholder history, click here.